MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment

Clinical trial NCT06177028 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06177028
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cognitive Impairment, Mild Cognitive Dysfunction Amyloid Plaque Neurodegenerative Disease, Hereditary Inflammation, Brain

Start date: 2025-06-01
Primary completion: 2026-01-02
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.